AU2869899A - Cellular flip compositions for treatment of arteriosclerotic disorders - Google Patents

Cellular flip compositions for treatment of arteriosclerotic disorders

Info

Publication number
AU2869899A
AU2869899A AU28698/99A AU2869899A AU2869899A AU 2869899 A AU2869899 A AU 2869899A AU 28698/99 A AU28698/99 A AU 28698/99A AU 2869899 A AU2869899 A AU 2869899A AU 2869899 A AU2869899 A AU 2869899A
Authority
AU
Australia
Prior art keywords
compositions
treatment
arteriosclerotic disorders
cellular flip
flip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28698/99A
Inventor
Kenneth Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Elizabeths Medical Center of Boston Inc
Original Assignee
St Elizabeths Medical Ct
St Elizabeths Medical Center of Boston Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Elizabeths Medical Ct, St Elizabeths Medical Center of Boston Inc filed Critical St Elizabeths Medical Ct
Publication of AU2869899A publication Critical patent/AU2869899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28698/99A 1998-02-20 1999-02-19 Cellular flip compositions for treatment of arteriosclerotic disorders Abandoned AU2869899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7547198P 1998-02-20 1998-02-20
US60075471 1998-02-20
PCT/US1999/003558 WO1999042570A1 (en) 1998-02-20 1999-02-19 Cellular flip compositions for treatment of arteriosclerotic disorders

Publications (1)

Publication Number Publication Date
AU2869899A true AU2869899A (en) 1999-09-06

Family

ID=22125978

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28698/99A Abandoned AU2869899A (en) 1998-02-20 1999-02-19 Cellular flip compositions for treatment of arteriosclerotic disorders

Country Status (2)

Country Link
AU (1) AU2869899A (en)
WO (1) WO1999042570A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT413485B (en) * 2001-04-09 2006-03-15 Hemoteq Gmbh Stent for stabilizing blood vessels, useful for inhibiting restenosis after vascular intervention, is coated with peptide inhibitor of caspase

Also Published As

Publication number Publication date
WO1999042570A1 (en) 1999-08-26

Similar Documents

Publication Publication Date Title
AU2192501A (en) Modification of integrated circuits
IL138129A (en) Composition for therapy of estrogen-associated disorders
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU7456798A (en) Vertical furnace for the treatment of semiconductor substrates
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
HK1150756A1 (en) Antibiotic compositions for treatment of the ear
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU2001272852A1 (en) Composition for the treatment of migraine
AU2001233081A1 (en) Composition for treatment of stress
PL330981A1 (en) Compositions of throwafloxacin mesilate
AU2991299A (en) Monoterpenoid derivatives for treatment of cancer
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU4392199A (en) Medicinal compositions for treating evacuatory insufficiency
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
GB9800640D0 (en) Compositions for the reduction of scarring
AU2021601A (en) Composition for the treatment of dandruff
AU7670700A (en) Method for improving the stay-on properties of cosmetic compositions
AU4991300A (en) Processes for the synthesis of oligomers using phusphoramidite compositions
AU4144000A (en) Compositions for treating brain infarction
AU2869899A (en) Cellular flip compositions for treatment of arteriosclerotic disorders
AU3899100A (en) Treatment of hyperactivity disorders
AUPP687298A0 (en) Herbal compositions for treatment of gastrointestinal disorders
AU6330399A (en) Semiconductor structure for semiconductor components
AU3753500A (en) Methods of treating fibrinogen-related disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase